Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: Influenza (flu) vaccinations are required for all NIH staff members who have direct contact with patients. COVID-19 vaccines are recommended for persons 6 months of age and older. Researchers want to learn about immunity in NIH staff members who get a flu and/or COVID-19 vaccine.

Objective: To understand what happens to the body s immune system throughout the year after getting the flu and/or COVID-19 vaccine.

Eligibility: Adults ages 18 and older who work at NIH and plan to get the current season s flu vaccine and/or COVID-19 vaccine.

Design: Participants will not get any vaccines as part of this study. Participants will be screened with a medical history and medicine review. They will get a survey via email. It will ask about their flu and SARS-CoV-2 history and vaccinations. Participants will have 12 monthly visits at NIH. If during that year they get both flu and SARS-COV-2 vaccines, their participation will be extended. Once a month, participants will be contacted. They will discuss any new medicines, recent vaccinations, or changes in medical history. Once a month, participants will have blood drawn. Once a month, participants will have nasal sampling. A small, flat absorptive strip will be placed in the nostril to soak up mucus. Participants will press against the outside of their nostril with their finger for 1 minute. Participants may be able to collect samples at home and mail them to NIH if they are not able to visit in person. Participation will last for about 12 13 months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: f
View:

⁃ In order to be eligible to participate in this study, an individual must meet all of the following criteria:

• NIH staff members, at the time of enrollment.

• Able to provide informed consent.

• \>=18 years of age.

• Planning to receive the current influenza season s vaccine and/or an FDA-authorized or approved SARS-CoV-2 vaccine.

• Willing and able to undergo blood draws or home blood samplings and nasal sampling procedures.

• Willing and able to undergo at least one blood draw and one nasal sampling prior to receiving vaccine.

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Rani S Athota, Ph.D.
NIAIDCSUflu@niaid.nih.gov
Not Listed
Backup
Alison Han, M.D.
alison.han@nih.gov
(301) 496-2209
Time Frame
Start Date: 2021-08-19
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 150
Treatments
Vaccinated
Received influenza and/or SARS-CoV-2 vaccine
Related Therapeutic Areas
Sponsors
Leads: National Institute of Allergy and Infectious Diseases (NIAID)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials